Who Supplies Sunitinib? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Sunitinib exports, with 114+ registered manufacturers shipping to buyers across 76+ countries — yet a handful of companies dominate the shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest share at 58.6% (export value: $37.3M). Close behind, DR REDDYS LABORATORIES LIMITED (8.2%, $5.2M). SUN PHARMACEUTICAL INDUSTRIES LTD (7.8%, $5.0M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Sunitinib? Top Manufacturers & Their Buyers
Flow of Sunitinib from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Sunitinib Supplier Network — Key Market Intelligence
The Sunitinib export market from India is led by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone commands a 58.6% share, shipping $37.3M worth of product across 138 shipments. The second-largest exporter, DR REDDYS LABORATORIES LIMITED, contributes $5.2M (8.2%) to the overall market. Combined, the top two suppliers alone account for 66.8% of all Sunitinib exports, indicating a relatively concentrated supply base.
Across all 114 tracked manufacturers, the total Sunitinib export value stands at $63.6M from 607 shipments. The market average shipment value is $104.8K. The single largest buyer relationship in terms of trade value is TARO PHARMACEUTICALS USA INC.,, receiving $28.1M worth of product.
The combined buyer network spans 13 named purchasing companies, including TARO PHARMACEUTICALS USA INC.,, SUN PHARMACEUTICAL INDUSTRIES, NORTHSTAR DISTRIBUTION CENTER 8912, SUN PHARMA CANADA INC, DR REDDYS LABORATORI and 8 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the first-largest Sunitinib exporter from India, with a market share of 58.6% and a total export value of $37.3M across 138 shipments. Their average shipment value of $270.2K is above the market average of $104.8K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. TARO PHARMACEUTICALS USA INC., is the dominant customer, accounting for 75.4% of this supplier's tracked business. Top customers include:
• TARO PHARMACEUTICALS USA INC., — $28.1M across 104 shipments (75.4% of this supplier's total exports)
• SUN PHARMACEUTICAL INDUSTRIES — $4.9M across 18 shipments (13.0% of this supplier's total exports)
• NORTHSTAR DISTRIBUTION CENTER 8912 — $1.7M across 6 shipments (4.5% of this supplier's total exports)
• SUN PHARMA CANADA INC — $1.5M across 5 shipments (4.0% of this supplier's total exports)
• NORTHSTAR DISTRIBUTION CENTER 8912 — $1.2M across 4 shipments (3.1% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $270.2K is 158% above the market average of $104.8K, consistent with large-order contracts or value-added formulations.
2DR REDDYS LABORATORIES LIMITED
DR REDDYS LABORATORIES LIMITED is the second-largest Sunitinib exporter from India, with a market share of 8.2% and a total export value of $5.2M across 4 shipments. Their average shipment value of $1.3M is above the market average of $104.8K, suggesting premium or bulk contract pricing.
DR REDDYS LABORATORIES LIMITED serves 2 named buyers in our database. DR REDDYS LABORATORI is the dominant customer, accounting for 95.9% of this supplier's tracked business. Top customers include:
• DR REDDYS LABORATORI — $5.0M across 4 shipments (95.9% of this supplier's total exports)
• DR REDDY s LABORATOR — $212.4K across 0 shipments (4.1% of this supplier's total exports)
Key Insight: DR REDDYS LABORATORIES LIMITED's per-shipment value of $1.3M is 1137% above the market average of $104.8K, consistent with large-order contracts or value-added formulations.
3SUN PHARMACEUTICAL INDUSTRIES LTD
SUN PHARMACEUTICAL INDUSTRIES LTD is the third-largest Sunitinib exporter from India, with a market share of 7.8% and a total export value of $5.0M across 9 shipments. Their average shipment value of $552.6K is above the market average of $104.8K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LTD serves 2 named buyers in our database. XX RXXDYSXXABOXXTORX is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• XX RXXDYSXXABOXXTORX — $5.0M across 9 shipments (100.0% of this supplier's total exports)
• DR REDDYS BEIJING PH — $268 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LTD's per-shipment value of $552.6K is 427% above the market average of $104.8K, consistent with large-order contracts or value-added formulations.
4MSN LABORATORIES PRIVATE LIMITED
MSN LABORATORIES PRIVATE LIMITED is the fourth-largest Sunitinib exporter from India, with a market share of 3.3% and a total export value of $2.1M across 42 shipments. Their average shipment value of $50.6K is below the market average of $104.8K, reflecting a high-volume, competitive pricing strategy.
MSN LABORATORIES PRIVATE LIMITED serves 2 named buyers in our database. SUN PHARMACEUTICAL INDUSTRIES is the dominant customer, accounting for 94.4% of this supplier's tracked business. Top customers include:
• SUN PHARMACEUTICAL INDUSTRIES — $2.0M across 40 shipments (94.4% of this supplier's total exports)
• NORTHSTAR DISTRIBUTION CENTER 8912 — $119.9K across 2 shipments (5.6% of this supplier's total exports)
Key Insight: MSN LABORATORIES PRIVATE LIMITED operates with high shipment frequency (42 shipments) at a per-shipment value of $50.6K, indicating a broad distribution network with many smaller, regular orders.
5CAPLIN POINT LABORATORIES LIMITED
CAPLIN POINT LABORATORIES LIMITED is the fifth-largest Sunitinib exporter from India, with a market share of 1.5% and a total export value of $949.6K across 6 shipments. Their average shipment value of $158.3K is above the market average of $104.8K, suggesting premium or bulk contract pricing.
CAPLIN POINT LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TO THE ORDER OF — $390.9K across 2 shipments (41.2% of this supplier's total exports)
• MSN LABS PERU SAC — $279.9K across 2 shipments (29.5% of this supplier's total exports)
• WORLD HEALTH ORGANIZ — $243.6K across 2 shipments (25.7% of this supplier's total exports)
• MSN LABORATORIES EUR — $18.8K across 0 shipments (2.0% of this supplier's total exports)
• MSN LABORATORIES EUR — $16.4K across 0 shipments (1.7% of this supplier's total exports)
Key Insight: CAPLIN POINT LABORATORIES LIMITED's per-shipment value of $158.3K is 51% above the market average of $104.8K, consistent with large-order contracts or value-added formulations.
6JODAS EXPOIM PRIVATE LIMITED
JODAS EXPOIM PRIVATE LIMITED is the fifth-largest Sunitinib exporter from India, with a market share of 0.8% and a total export value of $531.8K across 16 shipments. Their average shipment value of $33.2K is below the market average of $104.8K, reflecting a high-volume, competitive pricing strategy.
JODAS EXPOIM PRIVATE LIMITED serves 3 named buyers in our database. NUEVOS ETICOS NEOETHICALS S A is the dominant customer, accounting for 99.1% of this supplier's tracked business. Top customers include:
• NUEVOS ETICOS NEOETHICALS S A — $527.0K across 16 shipments (99.1% of this supplier's total exports)
• NEOETHICALS S.A — $4.4K across 0 shipments (0.8% of this supplier's total exports)
• NEOETHICALS S.A — $405 across 0 shipments (0.1% of this supplier's total exports)
Key Insight: JODAS EXPOIM PRIVATE LIMITED operates with high shipment frequency (16 shipments) at a per-shipment value of $33.2K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Sunitinib Flows
Once Sunitinib leaves the manufacturing plants of companies like SUN PHARMACEUTICAL INDUSTRIES LIMITED and DR REDDYS LABORATORIES LIMITED, it travels to 5 destination markets with a combined import value of $63.6M. Canada absorbs the largest share at 50.5% ($32.1M), followed by United States (38.4%) and Peru (2.5%).
In Canada — the top destination — named importers include TARO PHARMACEUTICALS INC.,, SUN PHARMA CANADA INC, SUN PHARMA ANZ PTY LTD. In United States, key buyers are SUN PHARMACEUTICAL INDUSTRIES,INC., NORTHSTAR DISTRIBUTION CENTER 8912, SUN PHARMACEUTICAL INDUSTRIES INC.
This geographic spread reflects Sunitinib's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Sunitinib Go? Top Importing Countries & Their Buyers
Trade flow of Sunitinib exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Canada
Canada ranks as the first-largest destination for Sunitinib imports from India, with a total trade value of $32.1M across 36 shipments — representing a 50.5% share of all Sunitinib exports. The average shipment value of $892.1K is above the global average of $104.8K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.
Named Sunitinib importers in Canada: TARO PHARMACEUTICALS INC., is the largest buyer, accounting for 89.1% ($28.6M) of this market's total imports.
• TARO PHARMACEUTICALS INC., — $28.6M (89.1% of Canada's total)
• SUN PHARMA CANADA INC — $1.5M (4.6% of Canada's total)
• SUN PHARMA ANZ PTY LTD — $1.1M (3.4% of Canada's total)
Key Insight: Canada's per-shipment average of $892.1K (751% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Sunitinib imports from India.
2United States
United States ranks as the second-largest destination for Sunitinib imports from India, with a total trade value of $24.4M across 60 shipments — representing a 38.4% share of all Sunitinib exports. The average shipment value of $406.8K is above the global average of $104.8K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Sunitinib importers in United States: SUN PHARMACEUTICAL INDUSTRIES,INC. is the largest buyer, accounting for 28.4% ($6.9M) of this market's total imports.
• SUN PHARMACEUTICAL INDUSTRIES,INC. — $6.9M (28.4% of United States's total)
• NORTHSTAR DISTRIBUTION CENTER 8912 — $3.5M (14.4% of United States's total)
• SUN PHARMACEUTICAL INDUSTRIES INC — $2.9M (11.9% of United States's total)
Key Insight: United States's per-shipment average of $406.8K (288% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Sunitinib imports from India.
3Peru
Peru ranks as the third-largest destination for Sunitinib imports from India, with a total trade value of $1.6M across 11 shipments — representing a 2.5% share of all Sunitinib exports. The average shipment value of $145.8K is above the global average of $104.8K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Sunitinib importers in Peru: SUN PHARMACEUTICAL INDUSTRIES is the largest buyer, accounting for 56.8% ($910.4K) of this market's total imports.
• SUN PHARMACEUTICAL INDUSTRIES — $910.4K (56.8% of Peru's total)
• MSN LABS PERU SAC — $279.9K (17.5% of Peru's total)
Key Insight: Peru's per-shipment average of $145.8K (39% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Peru is a key market for Sunitinib imports from India.
4Belgium
Belgium ranks as the fourth-largest destination for Sunitinib imports from India, with a total trade value of $1.2M across 21 shipments — representing a 1.9% share of all Sunitinib exports. The average shipment value of $58.3K is below the global average of $104.8K, consistent with generic/API volume purchasing. This market is served by 1 tracked buyer.
Named Sunitinib importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 100.0% ($1.2M) of this market's total imports.
• YUSEN LOGISTICS BENELUX BELGIUM — $1.2M (100.0% of Belgium's total)
Key Insight: Belgium receives frequent, smaller shipments of Sunitinib — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Belgium is a key market for Sunitinib imports from India.
5Australia
Australia ranks as the fifth-largest destination for Sunitinib imports from India, with a total trade value of $994.3K across 3 shipments — representing a 1.6% share of all Sunitinib exports. The average shipment value of $331.4K is above the global average of $104.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Sunitinib importers in Australia: SUN PHARMA ANZ PTY LIMITED is the largest buyer, accounting for 28.3% ($281.5K) of this market's total imports.
• SUN PHARMA ANZ PTY LIMITED — $281.5K (28.3% of Australia's total)
Key Insight: Australia's per-shipment average of $331.4K (216% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Australia is a key market for Sunitinib imports from India.
People Also Ask — Sunitinib Supplier & Trade Network
Who are the top suppliers of Sunitinib from India?+
Which companies buy Sunitinib from Indian manufacturers?+
Where does Sunitinib exported from India go?+
What is the market share of the top Sunitinib supplier from India?+
What is the average shipment value for Sunitinib exports from India?+
Is Sunitinib manufactured in India and exported globally?+
Which country imports the most Sunitinib from India?+
Who are the buyers of Sunitinib in United States?+
How concentrated is the Sunitinib supplier market in India?+
How do I find verified buyers for Sunitinib in specific countries?+
Sunitinib Trade Network — Key Takeaways
- 1SUN PHARMACEUTICAL INDUSTRIES LIMITED is India's dominant Sunitinib exporter with a 58.6% market share and $37.3M in total exports — making it the single most important sourcing entity in this market.
- 2The top 114 suppliers collectively account for 80.3% of all tracked Sunitinib exports, with a combined trade value of $63.6M.
- 3Canada is the largest destination market, absorbing 50.5% of India's Sunitinib exports ($32.1M). United States (38.4%) and Peru (2.5%) follow.
- 4With 607 total shipments averaging $104.8K each, the Sunitinib export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include TARO PHARMACEUTICALS USA INC.,, SUN PHARMACEUTICAL INDUSTRIES, DR REDDYS LABORATORI, DR REDDY s LABORATOR — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 76 countries
Network value: $63.6M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Sunitinib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Sunitinib.
- 2.Flow Mapping: 114 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 607 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 76 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
607 Verified Shipments
114 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists